Founded with a mission to revolutionize drug discovery, Octant, Inc. is a biotechnology company based in the United States. The company aims to map a new universe of medicine by developing next-generation small molecule therapeutics. Utilizing synthetic biology, genome engineering, next-generation sequencing, and computational tools, Octant focuses on drugging the cellular mechanisms that cause disease. Their innovative approach moves beyond traditional methods by engineering biology to measure the activity of receptor pathways in human cells.
Octant has attracted notable investors and industry leaders, contributing to its rapid growth and recognition in the biotech sector. The company's key achievements include the development of multiplexed technologies that significantly enhance the precision and efficiency of drug discovery processes. By pioneering these advanced genomic and computational tools, Octant has made a substantial impact on the field of biotechnology, offering promising new avenues for treating complex diseases.
